🧬 SinoBioData Academic Portal
Open AccessDOI: 10.1093/gpb/art_1113Original Research

Microbiome in Female Reproductive Health: Implications for Fertility and Assisted Reproductive Technologies

🇨🇳 Original Chinese Title: Microbiome in Female Reproductive Health: Implications for Fertility and Assisted Reproductive Technologies

Liwen Xiao¹,Zhenqiang Zuo¹,Fangqing Zhao¹

CAS Key Laboratory of Systems Biology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China

Read Executive PreviewQuick FAQ
Microbiome in Female Reproductive Health: Implications for Fertility and Assisted Reproductive Technologies
Graphical Abstract / Figure
Published In
Genomics, Proteomics & Bioinformatics
Published:2024Edition:Vol. 32, Issue 1Citation:Liwen Xiao et al. (2024), Genomics, Proteomics & Bioinformatics
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Genomics, Proteomics & Bioinformatics (基因组蛋白质组与生物信息学报).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • The microbiome in the female reproductive tract is crucial for conception and pregnancy outcomes, with dysbiosis linked to complications like GDM and preeclampsia. • Restoring microbiome balance may improve fertility and ART success, offering potential for microbiome-based interventions. • Microbial biomarkers show promise as indicators for early detection of pregnancy disorders. • Comprehensive understanding of microbiome dynamics before and during pregnancy is essential for advancing ART and maternal-fetal health.
Sponsored Research Highlight

Abstract

The microbiome plays a critical role in the process of conception and the outcomes of pregnancy. Disruptions in microbiome homeostasis in women of reproductive age can lead to various pregnancy complications, which significantly impact maternal and fetal health. Recent studies have associated the microbiome in the female reproductive tract (FRT) with assisted reproductive technology (ART) outcomes, and restoring microbiome balance has been shown to improve fertility in infertile couples. This review provides an overview of the role of the microbiome in female reproductive health, including its implications for pregnancy outcomes and ARTs. Additionally, recent advances in the use of microbial biomarkers as indicators of pregnancy disorders are summarized. A comprehensive understanding of the characteristics of the microbiome before and during pregnancy and its impact on reproductive health will greatly promote maternal and fetal health. Such knowledge can also contribute to the development of ARTs and microbiome-based interventions.

1. Introduction

With rapid social and economic development, female reproductive health has received increasing attention. There have been various proactive lifestyle recommendations to promote reproductive health, such as engaging in regular exercise and maintaining a balanced diet that includes high-fiber food [1,2]. Recent studies have indicated that the microbiome also plays a crucial role in successful pregnancy and favorable pregnancy outcomes [3,4]. Microbiome refers to the community of all commensal, symbiotic, and pathogenic microorganisms within a body or other environment, and their habitat [5]. Previous studies have shown that the microbiome plays an essential role in the healthy development of the human body and the onset of various diseases [6–8]. Microbiomes in different parts of the human body exhibit different dynamic patterns throughout different life stages, with pregnancy being one of the most critical life stages [9–12]. Previous studies focusing on mothers and babies during the perinatal period have shown frequent microbial interaction and transmission across various body sites, indicating the importance of microbial homeostasis, particularly in the gut and reproductive tract, for the health of both mothers and infants during this critical time window [9,13]. Emerging studies also suggest that the depletion of certain bacteria in early life may lead to significant health issues in childhood [14–16]. Therefore, investigating the characteristics of the microbiome before and during pregnancy, as well as understanding how the microbial variations impact pregnancy health and delivery outcomes, not only contributes to the development of risk prediction models, but also provides targets for microbiome-based interventions to improve reproductive health.

In modern times, unhealthy lifestyles have remarkably increased the incidence of pregnancy complications. These illnesses during pregnancy have a noticeable impact on healthy reproduction. Over the past few decades, the prevalence of infertility has led to the growth of assisted reproductive technologies (ARTs) [17], which provide hope to many couples facing reproductive difficulties. ART refers to any fertility-related treatment in which eggs or embryos are manipulated, with in vitro fertilization (IVF) being the main type [18]. The IVF process typically involves retrieving eggs and sperm, fertilizing the eggs, culturing and screening the embryos, and finally transferring an appropriate embryo into the uterus [18]. Recently, a lot of studies have associated the microbiome in the female reproductive tract (FRT) with ART outcomes and provided some interesting observations [19–23]. However, due to inconsistent conclusions among different studies, the progress of ARTs remains limited. A comprehensive understanding of the role of the microbiome in the ART process is crucial and urgently needed.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Liwen Xiao, Zhenqiang Zuo, Fangqing Zhao (2026). Microbiome in Female Reproductive Health: Implications for Fertility and Assisted Reproductive Technologies. Genomics, Proteomics & Bioinformatics. https://doi.org/10.1093/gpb/art_1113
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the role of the microbiome in female reproductive health?

The microbiome in the female reproductive tract plays a critical role in conception and pregnancy outcomes. Disruptions in microbiome homeostasis can lead to pregnancy complications such as gestational diabetes mellitus and preeclampsia, impacting maternal and fetal health.

How does the microbiome affect assisted reproductive technology (ART) outcomes?

Recent studies have associated the microbiome in the female reproductive tract with ART outcomes. Restoring microbiome balance has been shown to improve fertility in infertile couples, suggesting that microbiome-based interventions could enhance ART success.

What are microbial biomarkers and how are they used in pregnancy?

Microbial biomarkers are indicators derived from the microbiome that can be used to predict or diagnose pregnancy disorders. Recent advances have summarized their potential in early detection and risk assessment of pregnancy complications.

Why is understanding the microbiome before and during pregnancy important?

Understanding the characteristics of the microbiome before and during pregnancy is crucial for developing risk prediction models and microbiome-based interventions to improve reproductive health, ultimately promoting maternal and fetal health.

What are the implications of this review for future research and clinical practice?

This review highlights the need for comprehensive understanding of microbiome dynamics in the female reproductive tract to advance ART and develop targeted interventions. It also underscores the potential of microbial biomarkers for early detection of pregnancy disorders, which could improve clinical outcomes.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF